Loading...
OTCMLANRF
Market cap8kUSD
Dec 16, Last price  
0.01USD
Name

NeonMind Biosciences Inc

Chart & Performance

D1W1MN
OTCM:LANRF chart
P/E
P/S
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
0k
415,803000
Net income
0k
P
-2,677,195-7,207,507-2,034,3520
CFO
-1m
L+4.65%
-853,447-5,820,956-1,080,848-1,131,160

Profile

NeonMind Biosciences Inc. engages in the discovery, development, and commercialization of medicinal and psychedelic mushrooms for mental illnesses. It is developing psilocybin-based products comprising mushroom-infused products and other mushroom-infused products to treat weight loss and management. The company was formerly known as Flourish Mushroom Labs Inc. and changed its name to NeonMind Biosciences Inc. in April 2020. NeonMind Biosciences Inc. was incorporated in 2019 and is based in Oakville, Canada. NeonMind Biosciences Inc. is a subsidiary of The Yield Growth Corp.
IPO date
Jan 04, 2021
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFY
2024‑032022‑112021‑112020‑112019‑11
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT